Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
BMS Bails on Checkpoint Inhibitor Teaming with CytomX, Stock Sinks
BioSpace
Tue, 03/12/24 - 06:54 pm
Bristol Myers Squibb
CytomX
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
Bristol Myers, overshadowed by ADC rival, wins FDA nod for Opdivo combo in bladder cancer
Fierce Pharma
Fri, 03/8/24 - 11:54 am
Bristol Myers Squibb
Opdivo
FDA
bladder cancer
Bristol Myers Squibb reports data from Phase III multiple sclerosis trial
Clinical Trials Arena
Fri, 03/1/24 - 11:39 am
Bristol Myers Squibb
clinical trials
Zeposia
MS
multiple sclerosis
Why is pharma going gaga for radiopharmaceuticals?
Pharmaphorum
Tue, 02/27/24 - 11:19 am
radiopharmaceuticals
oncology
Novartis
Eli Lilly
Bristol Myers Squibb
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
Reuters
Tue, 02/27/24 - 11:17 am
Bristol Myers Squibb
R&D
India
Bristol Myers Squibb invests over $400m in sterile drug product facility
Biopharma Reporter
Thu, 02/22/24 - 11:38 am
Bristol Myers Squibb
drug manufacturing
Europe
Dublin
Ireland
Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing
Fierce Pharma
Wed, 02/21/24 - 11:25 am
Novo Nordisk
Novartis
JNJ
Bristol Myers Squibb
legal
Inflation Reduction Act
drug pricing
BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues
Fierce Biotech
Tue, 02/13/24 - 11:31 am
Bristol Myers Squibb
Roivant
VantAI
artificial intelligence
molecular glue
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive
Fri, 02/9/24 - 11:26 am
Senate
drug pricing
Pharma CEOs
Bristol Myers Squibb
Chris Boerner
JNJ
Joaquin Duato
Merck
Rob Davis
PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US
Fierce Pharma
Thu, 02/8/24 - 10:08 pm
Bernie Sanders
drug pricing
Pharma CEOs
Senate
Merck
Bristol Myers Squibb
JNJ
Rob Davis
Chris Boerner
Joaquin Duato
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
Fierce Pharma
Tue, 02/6/24 - 11:33 pm
Bernie Sanders
drug pricing
Merck
JNJ
Bristol Myers Squibb
Pharma CEOs
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti
Fierce Pharma
Sun, 02/4/24 - 12:39 pm
Bristol Myers Squibb
Abecma
FRDA
CAR-T
JNJ
Carvykti
Bristol Myers CEO sees mid-decade transition, late decade growth
Reuters
Sun, 02/4/24 - 12:35 pm
Bristol Myers Squibb
Pharma CEOs
Chris Boerner
BMS more likely to bet on bolt-ons after recent buying spree
Fierce Biotech
Fri, 02/2/24 - 11:59 am
Bristol Myers Squibb
M&A
earnings
Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
BioPharma Dive
Tue, 01/30/24 - 11:10 am
Cour Pharmaceuticals
funding
autoimmune disease
Roche
Pfizer
Bristol Myers Squibb
nanoparticles
BMS' subcutaneous Opdivo clears first phase 3 trial
Pharmaphorum
Mon, 01/29/24 - 11:06 am
Bristol Myers Squibb
Opdivo
clinical trials
kidney cancer
subcutaneous Opdivo
BMS won out against other pharmas in bid for RayzeBio, just days after competing for Karuna
Fierce Biotech
Thu, 01/25/24 - 09:02 pm
Bristol Myers Squibb
M&A
Rayze Bio
radiopharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »